Table 1. Demographic data and clinical characteristics of the patients and controls (T-test p values are indicated). Abbreviations: SD, standard deviation, yrs, years, AED, antiepileptic drug, na, not applicable.
| - | TLE | HC | p value |
|---|---|---|---|
| No. | 52 | 40 | - |
| Gender (male/female) | 24/28 | 24/16 | p > 0.05 |
| Age, mean ± SD (yrs) | 43.04 ± 18.27 | 47.94 ± 9.81 | p > 0.05 |
| Age of onset, mean ± SD (yrs) | 24.47 ± 19.65 | na | - |
| Disease duration, mean ± SD (yrs) | 18.57 ± 17.38 | na | - |
| Family history of epilepsy, N (%) Yes No |
18 (36%) 32 (64%) |
na | - |
| Seizure frequency, N (%) Daily Weekly Monthly |
7 (14%) 12 (24%) 31 (62%) |
na | - |
| EEG, N (%) Bilateral Left Right |
10 (19,61%) 24 (47,05%) 17 (33,34%) |
na | - |
| Hippocampal Sclerosis, N (%) Bilateral Left Right No Sclerosis |
1 (2%) 3 (6%) 6 (12%) 40 (80%) |
na | - |
| Febrile Seizures, N (%) Yes No |
13 (26%) 37 (74%) |
na | - |
| Focal to Bilateral Tonic-Clonic Seizures, N (%) Yes No |
42 (84%) 12 (24%) |
- | - |
| AED therapy at the last clinic visit, N (%) Monotherapy Polytherapy |
21 (40,39%) 31 (59,61%) |
na | - |
| Drug-responsive, N (%) | 36 (69.23%) | na | - |
| Drug-resistant, N (%) | 16 (30.77%) | na | - |